- Research works
- 28 ▼ 51% vs 2013–17
- Citations
- 429 15.5 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 35% world 28%
Not ranked overall: StemCyte is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at StemCyte?
Ranked on the composite score, Lawrence D. Petz lead among researchers whose main affiliation is StemCyte.
- 1 Lawrence D. Petz United States · #132,826 worldwide 97 citations · 29 works
Which keywords describe research at StemCyte?
By fractional works in all years, weighted toward what it does more of than the world: Mesenchymal Stem Cells, Hematopoietic Stem Cells, Bone Marrow Niche, Graft-versus-Host Disease, Monoclonal Antibodies, Therapeutic Antibodies, Transplantation and Glycosylation.
- Primary Immunodeficiency
- Merkel Cell Carcinoma
- Kidney Transplantation
- Genetic Mutations
- Regeneration
- Thalassemia
- Piezo2
- Protein Aggregation
- Biopharmaceuticals
- Epidemiology
- Antibody Engineering
- Alloimmunization
- Glycosylation
- Therapeutic Antibodies
- Graft-versus-Host Disease
- Hematopoietic Stem Cells
- Mesenchymal Stem Cells
- Bone Marrow Niche
- Monoclonal Antibodies
- Transplantation
- Anemia
- Blood Groups
- Fc Receptors
- Pulmonary Hypertension
- Differentiation
- Piezo1
- Sickle-cell Disease
- Multipotent
- Immunosuppression
- Rejection
- Immune Dysregulation
- Polyomavirus
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 32 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 32 words, with their numbers
- Mesenchymal Stem Cells6▲ 168×2 topics
- Hematopoietic Stem Cells5▲ 164×3 topics
- Bone Marrow Niche4▲ 434×1 topic
- Graft-versus-Host Disease4▲ 434×1 topic
- Monoclonal Antibodies4▲ 98×2 topics
- Therapeutic Antibodies4▲ 110×2 topics
- Transplantation3▲ 94×4 topics
- Glycosylation3▲ 45×3 topics
- Anemia3▲ 81×2 topics
- Alloimmunization2▲ 238×1 topic
- Blood Groups2▲ 238×1 topic
- Antibody Engineering2▲ 81×1 topic
- Fc Receptors2▲ 81×1 topic
- Epidemiology2▲ 1.62×4 topics
- Pulmonary Hypertension2▲ 38×2 topics
- Biopharmaceuticals2▲ 88×1 topic
- Differentiation2▲ 81×2 topics
- Protein Aggregation2▲ 76×1 topic
- Piezo12▲ 134×1 topic
- Piezo22▲ 134×1 topic
- Sickle-cell Disease2▲ 119×1 topic
- Thalassemia2▲ 119×1 topic
- Multipotent2▲ 134×1 topic
- Regeneration2▲ 29×1 topic
- Immunosuppression1▲ 43×3 topics
- Genetic Mutations1▲ 8.8×2 topics
- Rejection1▲ 90×2 topics
- Kidney Transplantation1▲ 57×2 topics
- Immune Dysregulation1▲ 44×1 topic
- Merkel Cell Carcinoma1▲ 175×1 topic
- Polyomavirus1▲ 175×1 topic
- Primary Immunodeficiency1▲ 89×1 topic
Which research topics does StemCyte publish most on?
By volume in 2022–2025: Acute Ischemic Stroke Management, Neuroinflammation and Neurodegeneration Mechanisms and Mesenchymal stem cell research.
- 1 Acute Ischemic Stroke Management Epidemiology 0 works
- 2 Neuroinflammation and Neurodegeneration Mechanisms Neurology 0 works
- 3 Mesenchymal stem cell research Genetics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has StemCyte's research output changed?
Output in 2018–2022 was 51% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Baldwin Park
- Applied Sciences Laboratory (United States)
- Kaiser Permanente Baldwin Park Medical Center
- Front Edge Technology (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.